Susquehanna International Group, LLP Rvl Pharmaceuticals PLC Transaction History

Susquehanna International Group, LLP

  • $527 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.08 - $0.55 $2,480 - $17,053
31,006 New
31,006 $2,000
Q1 2023

May 16, 2023
BUY
$1.02 - $1.39 $7,085 - $9,656
6,947 Added 5.75%
127,853 $145,000
Q4 2022

Feb 14, 2023
BUY
$1.02 - $1.61 $108,367 - $171,051
106,243 Added 724.57%
120,906 $135,000
Q3 2022

Nov 14, 2022
BUY
$1.28 - $2.91 $18,768 - $42,669
14,663 New
14,663 $31,000
Q1 2022

May 16, 2022
BUY
$1.03 - $2.01 $11,282 - $22,017
10,954 New
10,954 $19,000

Others Institutions Holding RVLP

# of Institutions
1
Shares Held
92.5K
Call Options Held
0
Put Options Held
0
View Full List

About RVL Pharmaceuticals plc

RVLP Quotes by TradingView
  • Ticker RVLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,150,000
  • Description
  • RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...
More about RVLP
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email